In the original article, old type of electrodes were incorrectly identified as (NM-990W) instead of (NM-983W). In addition, the average of P-IES in non-diabetic/IFG subjects was incorrect. The correct value is “0.15 ± 0.01.”
A correction has been made in the following places:
The Material and Methods section, subsection P-IES Measurement, paragraph 1:
“For nociceptive stimulation, an IES method was adopted using a disposable concentric bipolar needle electrode (NM-983W; Nihon Kohden Corp., Tokyo, Japan) which was connected to a specific stimulator for cutaneous Aδ and C fibers as previously described (PNS-7000; Nihon Kohden) (15).”
The Abstract, subsection Results:
“P-IES was elevated with increasing of age in women but not in men. Average P-IES (mA) was increased in IFG subjects (n = 55, 0.20 ± 0.03) compared with normoglycemic/non-IFG individuals (n = 894, 0.15 ± 0.01) (p < 0.01). It was comparable between IFG and a group of normal high HbA1c (5.9–6.4%). Univariate linear regression analyses showed no influence of sex, triglyceride, or cholesterol on the value of P-IES. In contrast, there were significant correlations between P-IES and serum HbA1c level (ß = 0.120, p < 0.001) Adjustments for the multiple clinical measurements confirmed positive correlation of P-IES with HbA1c (ß = 0.077, p = 0.046).”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Summary
Keywords
small fiber dysfunction, diabetic polyneuropathy, HbA1c, painful, small fiber assessment
Citation
Itabashi C, Mizukami H, Osonoi S, Takahashi K, Kudo K, Wada K, Inaba W, Danyang G, Uchida C, Umetsu S, Igawa A, Ogasawara S, Ryuzaki M, Komeda K, Ishibashi Y, Yagihashi S and Nakaji S (2020) Corrigendum: Normal High HbA1c a Risk Factor for Abnormal Pain Threshold in the Japanese Population. Front. Endocrinol. 11:130. doi: 10.3389/fendo.2020.00130
Received
02 January 2020
Accepted
26 February 2020
Published
10 March 2020
Volume
11 - 2020
Edited and reviewed by
Jan Polák, Charles University, Czechia
Updates
Copyright
© 2020 Itabashi, Mizukami, Osonoi, Takahashi, Kudo, Wada, Inaba, Danyang, Uchida, Umetsu, Igawa, Ogasawara, Ryuzaki, Komeda, Ishibashi, Yagihashi and Nakaji.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Hiroki Mizukami hirokim@hirosaki-u.ac.jp
This article was submitted to Clinical Diabetes, a section of the journal Frontiers in Endocrinology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.